Expertise in
2
conditions

Dr. Marie Bleakley

Oncology
Fred Hutchinson Cancer Center
1100 Fairview Ave N, 
Seattle, WA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
28 Years of Experience
Expertise in
2
conditions
Fred Hutchinson Cancer Center
1100 Fairview Ave N, 
Seattle, WA 

Overview

Marie Bleakley is an Oncologist practicing medicine in Seattle, Washington. She has been practicing medicine for over 28 years.

Dr. Bleakley is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Leukemia, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Wilms Tumor.

She is actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 3 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in WA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO

Locations

Fred Hutchinson Cancer Center
1100 Fairview Ave N, Seattle, WA 98109
Other Locations
Seattle Children's Hospital
4800 Sand Point Way NE, Seattle, WA 98105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase I Study of Adoptive Immunotherapy With CD8+ and CD4+ Memory T Cells Transduced to Express an HA-1-Specific T Cell Receptor (TCR) for Children and Adults With Recurrent Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Phase I Study of Adoptive Immunotherapy With CD8+ and CD4+ Memory T Cells Transduced to Express an HA-1-Specific T Cell Receptor (TCR) for Children and Adults With Recurrent Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Enrollment Status: Recruiting
Publish Date: May 18, 2026
Intervention Type: Procedure, Biological
Study Drugs: HA-1 T Cell Receptor T Cells, Fludarabine
Study Phase: Phase 1
A Phase II Study Evaluating Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD
A Phase II Study Evaluating Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD
Enrollment Status: Completed
Publish Date: June 01, 2026
Intervention Type: Drug, Procedure, Radiation, Other
Study Drugs: Cyclophosphamide, Fludarabine, Methotrexate, Mycophenolate Mofetil, Tacrolimus, Thiotepa
Study Phase: Phase 2
A Phase II Study of Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children
A Phase II Study of Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Radiation, Procedure, Drug, Other, Biological
Study Drugs: Fludarabine, Methotrexate, Tacrolimus, Thiotepa, T Cell-Depleted Hematopoietic Stem Cell Transplant
Study Phase: Phase 2
View 2 Less Clinical Trial

51 Total Publications

Plant-based whole-food diets are feasible during auto-HCT and are associated with dose-dependent microbiome modulation.
Plant-based whole-food diets are feasible during auto-HCT and are associated with dose-dependent microbiome modulation.
Journal: Blood advances
Published: March 02, 2026
Similar Doctors
Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

Rachel Loschiavo PA-C

825 Eastlake Ave E, 
Seattle, WA 
 (3.3 miles away)
206-288-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ajay Gopal is an Oncologist practicing medicine in Seattle, Washington. Dr. Gopal is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Classical Hodgkin Lymphoma.

Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

Swedish Cardiovascular RSRCH

1221 Madison St Ste 1020, 
Seattle, WA 
 (4.7 miles away)
206-215-2658
Languages Spoken:
English
See accepted insurances

John Pagel is an Oncologist practicing medicine in Seattle, Washington. Dr. Pagel is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Rachel Loschiavo PA-C

825 Eastlake Ave E, 
Seattle, WA 
 (3.3 miles away)
206-520-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Petros Grivas is an Oncologist practicing medicine in Seattle, Washington. Dr. Grivas is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Endoscopy.

Frequently Asked Questions about Dr. Marie Bleakley

How do I make an appointment with Dr. Marie Bleakley?

You can book an appointment with Dr. Marie Bleakley by calling their office at 206-667-4886. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marie Bleakley a top-rated expert for Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marie Bleakley is classified as an Advanced expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marie Bleakley specialize in?

While Dr. Marie Bleakley is a Oncology, they have specific expertise in Leukemia, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Marie Bleakley participate in research or clinical trials?

Yes. Dr. Marie Bleakley has published 51 articles and abstracts on conditions like Leukemia. You can view a list of Dr. Marie Bleakley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marie Bleakley accept my insurance?

Dr. Marie Bleakley accepts most major insurance plans, including Humana and PacificSource. We recommend calling the office directly at 206-667-4886 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bleakley's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile